As of 30 June 2026, GSK plc reported issued share capital of 4,316,276,428 ordinary shares of 31 ¼ pence each. With 270,881,064 ordinary shares held in treasury, the total number of voting rights stands at 4,045,395,364. GSK is a global biopharma company focused on disease prevention and treatment.
